Genomics (HMGP 7620) Pharmacogenomics.

Similar documents
3. Describe how variants in the CYP2C19 gene impact Plavix metabolism. 4. Compare molecular genetic technologies for pharmacogenomics testing

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Variability Due to Genetic Differences

Pharmacogenomics-based individualization of drug therapy

Genetics and Genomics: Influence on Individualization of Medication Regimes

Thiopurine S-Methyltransferase (TPMT): Pharmacogenetic Competency

Genetic Screening for ADR

MEDICAL POLICY. Proprietary Information of YourCare Health Plan

Objectives. Clinical Problem. What if there were a way. Pharmacogenomics in Current Practice MEDICINE 12/1/2017

2/28/2010. Pharmacogenomics and the Asian Population. Limited efficacy/response to drugs already on the market

Pharmacogenomics in Current Practice. Trinh Pham, PharmD, BCOP Associate Clinical Professor University of Connecticut School of Pharmacy.

Falk Symposium 156: Genetics in Liver Disease. Pharmacogenetics. Gerd Kullak-Ublick

Deliverable 2.1 List of relevant genetic variants for pre-emptive PGx testing

Application of Pharmacogenetics Supplementary Worksheet

Pharmacogenomics In Psychiatry. Wolfgang Sadee OSU Program in Pharmacogenomics The Ohio State University. XGEN Group NIH PGRN

MEDICAL POLICY SUBJECT: GENOTYPING OR PHENOTYPING FOR THIOPURINE METHYLTRANSFERASE (TPMT) FOR PATIENTS TREATED WITH AZATHIOPRINE (6-MP)

Right drug. Right dose. Right now. Delivering on the promise and value of personalized prescribing

Pharmacogenomics: Genetic variations in drug metabolism and utilization. Disclosure

Implementing Pharmacogenetic Testing Into Clinical Laboratories. Elaine Lyon, PhD, & Gwen McMillin, PhD University of Utah ARUP Laboratories

Ron van Schaik. Pharmacogenetics. London, Oct 8-9, Clinical implementation: a 7 year experience

Pharmacogenetics in: Primary Care. Bradley T. Wajda D.O.

Two decades of clinical pharmacogenetic testing - Where do we stand?

Mujeeb U. Shad, M.D., M.S.C.S. Associate Professor of Psychiatry Oregon Health & Science University, Portland Oregon Supervising Psychiatrist Oregon

Tailoring Drug Therapy Based on Genotype. Larisa H. Cavallari, Pharm.D. Associate Professor, Department of Pharmacy Practice

Pharmacogenomics and Pharmacokinetics ^

Personalized Prescribing: Using Genetic Testing to Guide Drug and Dose Selection. Lindsay S. Elliott, Pharm.D., CGP

Perceived challenges in genomic-based drug development. Garret A. FitzGerald University of Pennsylvania

Drug Safety Pharmacosurveillance: The Future is Now & Spelled G-e-n-o-m-I-c-s

How many disease-causing variants in a normal person? Matthew Hurles

6. DOSE ADJUSTMENTS BASED ON PHARMACOGENETICS OF CYP450 ENZYMES

Review of Pharmacogenetic Testing Today

Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence

Pharmacogenetics to tailor Drug Exposure and Outcomes in Kidney Transplantation

Big data vs. the individual liver from a regulatory perspective

Cytochrome p450 Genotyping. Description. Section: Medicine Effective Date: July 15, 2015

Implémentation clinique de la pharmacogénétique

Pharmacogenomics of Antidepressant Medications

Please answer the following questions by circling the best response, or by filling in the blank.

Yes if indicated below. (4.0 TMPT does not require prior authorization)

PARACOD Tablets (Paracetamol + Codeine phosphate)

Pharmacokinetics, pharmacodynamics and pharmacogenetics of aripiprazole and olanzapine in healthy subjects

Professor John F. Peppin, DO, FACP Marian University, College of Osteopathic Medicine, Adjunct Faculty

Imipramine therapy (CYP2D6)

What#are#the#different#types#of#mutations#&#phenotypic#effects?#Give#an#example#of#a#disease#for#each.#

Cytochrome p450 Genotyping

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Systemic Medications for the Dermatology Toolbox: Azathioprine

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

PRODUCT INFORMATION CODAPANE XTRA Paracetamol 500 mg and Codeine Phosphate 15 mg Tablets

PHARMACOGENETICS. Marshalling the human genome to individualize drug therapy

USING GENETICS TO DRIVE TREATMENT: A FOCUS WARFARIN

Definition. The term pharmacogenetics was introduced by Vogel in 1959

Personalized Medicine: Pharmacogenetics From Bench to Bedside and Beyond

Personalized Medicine & Treatments

Personalized Medicine in Real Time

INDIVIDUALIZED PATIENT THERAPY: IS IT MORE THAN A BUZZWORD?

Precision Medicine Under the Big Sky

Gan GG Department of Medicine University Malaya Medical Centre Kuala Lumpur

Deriving Rules and Assertions From Pharmacogenomic Knowledge Resources In Support Of Patient Drug Metabolism Efficacy Predictions!

Pharmacogenomics of Medications for Pain and Major Depression: Promise and Peril

Review Article. Pharmacogenetics and anaesthesia: the value of genetic profiling. Summary. The history of pharmacogenetics related to anaesthesia

PRODUCT INFORMATION Panadeine EXTRA

Chapter Questions. Modern Pharmacology With Clinical Applications. Sixth Edition

Psychiatric genomics 2016: what the clinician needs to know

Basket and Umbrella Trial Designs in Oncology

Supplementary Text. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry

Utility of Pharmacogenomics to Identify and Limit CV Risk. Christopher B. Granger, MD

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA

Dihydropyrimidine Dehydrogenase (DPYD) Pharmacogenetic Competency

Opioid Use: Current Challenges & Clinical Advancements

Pharmacotherapy Issues in the Pediatric Population

Demystifying Pharmacogenetics: its evolution and challenges. June 15, 2016

General Discussion 4

Pharmacogenomics Gene/Drug-Pair Decision Flow Charts 2017

The effects of pharmacogenetics on adverse drug reactions. Jennifer Ramon. Drug treatment provokes a variety of responses in patients some are able to

WHAT S NEW. Vilazodone (Viibryd ) Vilazodone - Dosing ANTIDEPRESSANT UPDATE: What s New? The Cardiac Debate The Efficacy Debate?Pharmacogenomics?

Session Objectives. Clopidogrel Resistance. Clopidogrel (Plavix )

Beyond Traditional Treatments: the Roles of Molecular Medicine and Individualized Therapies

Are health care systems ready to deliver pharmacogenetics as standard of care? Predicting the needs and setting the strategies

Psychiatric Pharmacogenomics: Introduction and Applications

How to use pharmacogenetics to select patients for pharmaceutical care

Cytochrome P450 Drug Interaction Table Flockhart Table

Biomarkers for Psychiatric Drug Toxicity. Oct 24, 2008 Thomas R. Insel, M.D. Director, NIMH

Page 61 PHARMACOGENETIC AND TUMOUR DRUGS. Table 1. Genetic polymorphisms known to affect responses to anticancer drugs.

Pharmacogenetics and pharmacogenomics of anticancer agents R. Stephanie Huang and Mark J. Ratain. DOI: /caac.20002

Genomics and new molecular diagnostics

Variation in drug responses & Drug-Drug Interactions

Developmental and Pediatric Pharmacology

Do We Need Platelet Function Assays?

Acknowledgments. Variation in Drug Response 7/15/2015. Personalized / Precision Medicine: Genomes Guiding Treatment

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Mental Health DNA Insight WHITE PAPER

PHARMACOGENETICS OF BREAST CANCER

Original Policy Date

Pharmacogenomics: Increasing the safety and effectiveness of drug therapy

99 Chapter 8 Summary

DILI: Clinical Pharmacology Considerations for Risk Assessment

Participants Questions and Comments when Learning their Children s CYP2D6 Research Results

Transcription:

Genomics (HMGP 7620) Pharmacogenomics http://unlockinglifescode.org/explore/genomic-medicine/pharmacogenomics Matthew Taylor MD PhD matthew.taylor@ucdenver.edu

Variety is the Spice of Life

Current Model: ~One-Size-Fits-All Pharmacology Patients with Disease MD prescribes medication Some benefit, some (many) do not, medication stopped in those who survive their adverse events Fueled by trial and error

Definitions Pharmacogenetics: the study of differences in drug response due to allelic variation in genes affecting drug metabolism, efficacy, and toxicity Variable response due to individual gene(s) Pharmacogenomics: the genomic approach to pharmacogenetics, is concerned with the assessment of common genetic variants in the aggregate for their impact on the outcome of drug therapy. Variable response due to multiple loci across the genome

How might genes affect the prescriptions doctors write?

Morphine Level (ng/ml) Pharmacogenetics Case Full-term 7-day-old male infant difficulty feeding and lethargy Mother c/o episiotomy pain MD prescribes codeine/paracetamol (30mg/500mg) 2 bid constipation + somnolence 1 bid Day 12: infant has appetite + grey skin Codeine phosphate 30mg + Acetaminophen 325mg Morphine Levels Normal Infant Serum Morphine Milk Morphine Koren, et al Lancet 2006; 368: 704

Codeine Metabolism CYP2D6 10% ACTIVE Codeine (ProDrug) Morphine CYP3A4 80% Codeine-6- Glucuronide INACTIVE Norcodeine

Morphine Level (ng/ml) Morphine Levels Breast Milk Gene Drug Interaction Normal Serum Morphine Infant Milk Morphine Morphine 70 ng/ml (nl 0-12) Genotype CYP2D6 CYP 2D6*2A // CYP 2D6*2Ax2 Breast Milk fatal morphine overdose CYP2D6 CYP2D6 CYP2D6 Morphine (ACTIVE) Codeine (ProDrug) CYP2D6 CYP2D6 Morphine (normal levels)

Adverse Drug Reactions Lararou and Pomeranz JAMA 1998; 279;1200-1205

http://www.bing.com/images/search?q=take+your+medicine&form=hdrsc2#view=detail&id=6ef229e7ba5fc3014a15fadf9b175119f6ea018b&selectedindex=24

Principles of Drug Therapy Physician Prescribes a Medication Something Good Happens A B MD Prescribes Medication Something (good) Happens Medication Prescribed Biological Effect

Realities of Drug Therapy Physician Prescribes a Medication Anything goes A MD Prescribes Medication C B D X Pt Takes Drug Pt Doesn t Take Drug + Effect Side Effect No Effect + and Side Effect Drug Drug Interaction Prescription Changes Diagnoses Changes No Effect + / - Effect Medication Prescribed Medication Taken Biological Effect

Realities of Drug Biology Physician Prescribes a Medication Anything goes A B C D X Medication Prescribed Medication Taken Medication Absorbed Pharmacokinetics: Relationship between drug dose and [drug]; absorption, distribution, delivery, removal (phase I and II reactions) Biological Effect Pharmacodynamics: Relationship between drug concentrations and drug effects ; interaction with drug targets (cells, receptors, enzymes); interactions with other drugs / biological compounds ( Drug Activation ) Disease / Med List Changes

Most major drugs are effective in only 100% 80% 60% 40% 20% 0% Response Rate (Drug Efficacy) for Various Conditions Drug Efficacy Physicians Desk Reference, 54th Edn., 2000 25 to 60 percent of patients Wilkinson. NEJM 2005;352: 2211-21 Magic Bullet Alzheimer's Asthma Anti-Arrhythmics SSRIs Diabetes HCV Incontinence Migraine (acute) Migraine (prophylaxis) Oncology Osteoporosis Rheumatoid Arthritis Schizophrenia

The CYP450 Complex Gene products active in liver and intestinal epithelium 3 main families ( CYP1, CYP2, CYP3) 6 main genes (CYP1A1, CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) Phase I for ~90% of common drugs CYP3A4 ~40% of all common drugs Less genetic variation in CYP3A4 than other CYPs Important Point: Most CYPs function to inactivate drugs, but rarely are needed for activation CYP2D6: codeine morphine is classic example Thompson and Thompson Figure 18-3

Phenotypes and Genotypes Ethnic Variation Exists in Genotypes and Phenotypes Expected Mutations* Frameshift Splicing Nonsense Missense (some) * Based on assumption that gene in question is responsible for drug inactivation/elimination Expected Mutations* Increased copy number Missense (some) Thompson and Thompson Figure 18-4

Nortriptyline Metabolism NEJM 2003; 348:529-37c

Percent of population TMPT and 6MP Nat Rev Drug Dis 2004;3:739-48 Acute lymphoblastic leukemia of childhood Azathioprine 6-Mercaptopurine + Cures ALL - Myelosuppression - + Thiopurine-Smethyltransferase (TPMT) activity ~0.5% - - - - + + + - - Increasing TMPT Activity Toxic metabolite elimination by TPMT - Standard AZ or 6MP doses to TMPT L /TMPT L fatal myelosuppression; (10% of dose needed)

NEJM 2011; 364(12): 1144 1153

It cannot be emphasized too strongly that treatment of each patient is a highly individualized matter. FDA-approved labeling for warfarin (Coumadin) NDA 9-218/5-105

Variety is the Spice of Life "If it were not for the great variability among individuals medicine might as well be a science and not an art. William Osler 1892

Genomic Model: Pharmacogenetic Stratification MD genotypes her patients Patients with Disease Give Drug High Dose Low Dose Alternate Drug

Pharmacogeneticsgenomics Application of multiple genome wide markers (genetic, RNA, epigenetic, other biomarkers, etc.) to impact therapy

cdna Microarray for Prognosis Gene Expression Profiling, Rosenwald NEJM 2002 Diffuse Large-B-cell Lymphoma Common cause of adult lymphoma Chemo. cures in range of 35-40% Prognostic Predictors: Age, ECOG performance status, tumor stage, LDH level, extent of extranodal disease International Performance Index (IPI) Can differences in gene expression add to the prognostic information provided by IPI?

Objectives: Pharmacogenetics At the conclusion of this lecture you should be able to: Define pharmacogenetics and pharmacogenomics Explain the two major elements of response to drugs, pharmacokinetics and pharmacodynamics, Describe the central role of the CYP450 enzyme system in drug metabolism Understand key specific pharmacogenetic examples Appreciate the truism of the axiom Variety is the spice of life! Matthew.taylor@ucdenver.edu